Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Magnesium sulfate dried
Thornton & Ross Ltd
A06AD04
Magnesium sulfate dried
1mg/1mg
Powder
No Controlled Drug Status
Valid as a prescribable product
BNF: 01060400; GTIN: 5011309400519
EPSOM SALTS PAGE 1 PAGE 2 PAGE 3 Read the complete document
OBJECT 1 EPSOM SALTS BP Summary of Product Characteristics Updated 03-Mar-2016 | Thornton & Ross Ltd 1. Name of the medicinal product Epsom Salts BP 2. Qualitative and quantitative composition Magnesium Sulfate Heptahydrate BP 100% W/W. 3. Pharmaceutical form Crystals or Crystalline Powder. Brilliant colourless crystals or a white crystalline powder. 4. Clinical particulars 4.1 Therapeutic indications 1. For the relief of occasional constipation. 2. For the relief of pain from sprains, bruises and boils. 4.2 Posology and method of administration 1. Oral. As a dilute solution. 2. Cutaneous. As a concentrated solution or paste. Recommended doses and dosage schedules Indication 1 Adults and children over 12 years: 5-15g (1 3 teaspoons) to be taken as required in 250 ml of water, which may be flavoured with citrus juices. The elderly: To be used with caution, not exceeding the adult dose. Indication 2 As a wet dressing suitable for all ages: Dissolve one tablespoonful in a small cupful of warm water and apply with lint or cotton wool as required. 4.3 Contraindications Internal use is contraindicated in all cases of acute gastro-intestinal conditions (except constipation), renal impairment, and in children with intestinal parasitic diseases. DO NOT give internally to children under 12 years old. Hypersensitivity to magnesium sulfate. 4.4 Special warnings and precautions for use Keep out of the sight and reach of children. Avoid prolonged use. If symptoms persist for longer than 7 days consult your doctor. Laxatives should not be taken where there is severe abdominal pain. Osmotic laxatives may produce dehydration so sufficient water should always be taken. Use with caution in elderly or debilitated patients. 4.5 Interaction with other medicinal products and other forms of interaction Oral magnesium salts have the properties of antacids therefore it is recommended that this product is not taken within two to four hours of any other medicinal products to minimise interactions. There is a risk of metabolic alkalosis w Read the complete document